Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Lowered to $20 at RBC Capital

February 14, 2019 6:50 AM
RBC Capital analyst Randall Stanicky ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles